Stay updated on GSK2857916 & Pembrolizumab in RRMM Clinical Trial
Sign up to get notified when there's something new on the GSK2857916 & Pembrolizumab in RRMM Clinical Trial page.

Latest updates to the GSK2857916 & Pembrolizumab in RRMM Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA new revision entry v3.3.4 was added to the study record history, and revision v3.3.3 was removed to reflect the latest updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedAdded a new revision entry 'Revision: v3.3.3' to the Record History and removed the old 'HHS Vulnerability Disclosure' link and the 'Revision: v3.3.2' entry.SummaryDifference0.2%

- Check60 days agoChange DetectedAdded Revision: v3.3.2 and deleted Revision: v3.2.0 from the history.SummaryDifference0.1%

- Check67 days agoChange DetectedNotice about government funding and operating status is no longer displayed on the page.SummaryDifference0.5%

- Check81 days agoChange DetectedThe new screenshot shows only minor visual adjustments to the Record History page. No changes to version entries or study data are visible.SummaryDifference0.1%

- Check110 days agoChange DetectedAdded a government status notice and new version 3.2.0; removed the old version 3.1.0.SummaryDifference11%

Stay in the know with updates to GSK2857916 & Pembrolizumab in RRMM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK2857916 & Pembrolizumab in RRMM Clinical Trial page.